Sunday, February 17, 2013

• 3 Healthy Dow Stocks Boost Market Energy This Weekat Wall St. Cheat Sheet (Sun, Feb 17)

Saturday, February 16, 2013

• Does the Arthritis Market Have Growing Pains?at Motley Fool (Sat, Feb 16)
• Medicare Drug Costs to Be Reduced for Seniors, U.S. Saysat Bloomberg (Sat, Feb 16)

Friday, February 15, 2013

• Merck Finally Settles Over Vytorinat Seeking Alpha (Fri, Feb 15)
• Better Dividend: Merck or Pfizer?at Motley Fool (Fri, Feb 15)
• 5 High-Yield Blue Chips To Buy With Solid Upside Potentialat Seeking Alpha (Fri, Feb 15)
• Snapshot: High of 18 + Gophers win in OT + Wild lose in SO + Cruise ship finally docks + Meteor injures 100s in Russia + Mpls HS food fight leads to melee +Millionaire matchmaker help the rich find love — VIDEOat bizjournals.com (Fri, Feb 15)

Thursday, February 14, 2013

• Boys Getting Cervical Cancer Shots in Australia Boosts Gardasilat Bloomberg (Thu, Feb 14)
• News Summary: Merck settles cholesterol drug suitsAP (Thu, Feb 14)
• Merck settles investor suits on cholesterol drugsAP (Thu, Feb 14)
• P&G expects $200M to $275M in Venezuela chargesAP (Thu, Feb 14)
• Merck's Dynamic Duoat Motley Fool (Thu, Feb 14)
• Merck to Pay $688 Million to Settle Vytorin Litigationat Bloomberg (Thu, Feb 14)
• Merck to Pay $688 Million to Settle Class Action Lawsuitsat Motley Fool (Thu, Feb 14)
• Venezuela to Limit Medicine Prices After Chavez Devaluationat Bloomberg (Thu, Feb 14)
• Merck to pay $688 million to settle Enhance shareholder suitsat bizjournals.com (Thu, Feb 14)
• Why Venezuela's Devaluation Is Bitingat CNBC (Thu, Feb 14)
• P&G Employs Crowdfunding and 2 Dow Movers to Followat Wall St. Cheat Sheet (Thu, Feb 14)
• Dow Today: Merck (MRK) Lowerat TheStreet (Thu, Feb 14)
• Hedge Fund Kahn Brothers’ Stock Picks for 2013at Motley Fool (Thu, Feb 14)
• Merck Pays $688M To Settle Investor Suit on Enhance Trialat Fox Business (Thu, Feb 14)
• Merck To Pay $688 Million To Shareholders For Delaying Vytorin Resultsat Forbes (Thu, Feb 14)
• Merck Resolves Securities Class-Action Lawsuits Related to the ENHANCE TrialBusiness Wire (Thu, Feb 14)

Wednesday, February 13, 2013

• Lowered Forecasts, New Drug Designations, and Device Recalls: Healthcare Recapat Wall St. Cheat Sheet (Wed, Feb 13)
• Pfizer to Novartis Seen Gaining as Drought Ends: Healthat Bloomberg (Wed, Feb 13)

Add MRK News to My Yahoo!